Positive regulation of Clostridium difficile toxins

The toxigenic element of Clostridium difficile VPI 10463 contains a small open reading frame (ORF) immediately upstream of the toxin B gene (G. A. Hammond and J. L. Johnson, Microb. Pathog. 19:203-213, 1995). The deduced amino acid sequence of the ORF, which we have designated txeR, encodes a 22-kDa protein which contains a helix-turn-helix motif with sequence identity to DNA binding regulatory proteins. We used a DNA fragment containing the C. difficile toxin A repeating units (ARU) as a reporter gene to determine if txeR regulates expression from the toxin A and toxin B promoters in Escherichia coli. To test the affect of txeR on expression, we fused the ARU gene fragment in frame with the toxin promoters. The fusions expressed a 104-kDa protein that contained the epitopes for monoclonal antibody PCG-4, which we used to measure levels of recombinant ARU by enzyme-linked immunosorbent assay. When txeR was expressed in trans with the toxin B promoter-ARU fusion contained on separate low-copy-number plasmid, expression of ARU increased over 800-fold. Furthermore, when we tested the toxin A promoter fused to ARU, expression increased over 500-fold with txeR supplied in trans. Our results suggest that TxeR is a positive regulator that activates expression of the C. difficile toxins.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Johnson,et al.  Transcriptional analysis of the toxigenic element of Clostridium difficile. , 1997, Microbial pathogenesis.

[3]  S. Nakamura,et al.  Enhancement of Clostridium difficile toxin production in biotin-limited conditions. , 1996, Journal of medical microbiology.

[4]  J. Johnson,et al.  The toxigenic element of Clostridium difficile strain VPI 10463. , 1995, Microbial pathogenesis.

[5]  M. Wilm,et al.  The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.

[6]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[7]  R. Gilbert,et al.  Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B , 1995, Infection and immunity.

[8]  P. Mullany,et al.  Gene cloning in Clostridium difficile using Tn916 as a shuttle conjugative transposon. , 1994, Plasmid.

[9]  J. Bartlett.  Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  T. Wilkins,et al.  Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. , 1994, Microbial pathogenesis.

[11]  G. Corthier,et al.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.

[12]  A. Price,et al.  Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.

[13]  T. Wilkins,et al.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A , 1992, Infection and immunity.

[14]  J. Torres.  Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. , 1991, Journal of medical microbiology.

[15]  J. Johnson,et al.  Construction and expression of the complete Clostridium difficile toxin A gene in Escherichia coli , 1991, Infection and immunity.

[16]  T. Wilkins,et al.  Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y , 1991, Infection and immunity.

[17]  L. A. Barroso,et al.  Nucleotide sequence of Clostridium difficile toxin B gene , 1990, Nucleic Acids Res..

[18]  J. Johnson,et al.  Molecular characterization of the Clostridium difficile toxin A gene , 1990, Infection and immunity.

[19]  S. Cole,et al.  Studies of UV‐inducible promoters from Clostridium perfringens in vivo and in vitro , 1988, Molecular microbiology.

[20]  S. Cole,et al.  Complete nucleotide sequence and genetic organization of the bacteriocinogenic plasmid, pIP404, from Clostridium perfringens. , 1988, Plasmid.

[21]  T. Wilkins,et al.  Clostridium difficile: its disease and toxins , 1988, Clinical Microbiology Reviews.

[22]  G. Clark,et al.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc , 1986, Infection and immunity.

[23]  N. Sullivan,et al.  Enzyme-linked immunosorbent assay for Clostridium difficile toxin A , 1983, Journal of clinical microbiology.

[24]  S. Nakamura,et al.  Effect of Clindamycin on Cytotoxin Production by Clostridium difficile , 1982, Microbiology and immunology.

[25]  N. Sullivan,et al.  Purification and characterization of toxins A and B of Clostridium difficile , 1982, Infection and immunity.

[26]  Dm Jones.  Manual of Methods for General Bacteriology , 1981 .

[27]  J. Bartlett,et al.  Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation , 1979, Applied and environmental microbiology.

[28]  J. Bartlett,et al.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. , 1978, Gastroenterology.

[29]  C. Eichel-Streiber.  Molecular Biology of the Clostridium difficile Toxins , 1993 .